Nationally Notifiable Infectious Diseases and Conditions, United States: Weekly Tables

TABLE 1s. Weekly cases* of notifiable diseases, United States, U.S. Territories, and Non-U.S. Residents week ending May 28, 2022 (Week 21)
Reporting Area Invasive pneumococcal disease, all ages §
Confirmed Probable
Current weekPrevious 52 weeks Max †Cum YTD 2022 †Cum YTD 2021 †Current weekPrevious 52 weeks Max †Cum YTD 2022 †Cum YTD 2021 †
U.S. Residents, excluding U.S. Territories 101 453 5,120 3,378 3 14 127 73
New England 5 17 127 139 - 1 1 -
Connecticut - 6 29 37 - 0 - -
Maine 4 7 41 33 - 0 - -
Massachusetts - 9 - 44 - 0 - -
New Hampshire - 4 27 12 - 1 1 -
Rhode Island - 4 19 9 - 1 - -
Vermont 1 3 11 4 - 0 - -
Middle Atlantic 16 80 767 437 2 6 34 18
New Jersey - 12 78 87 - 3 14 16
New York (excluding New York City) 12 46 315 133 1 2 11 -
New York City - 22 184 131 - 6 - 1
Pennsylvania 4 17 190 86 1 2 9 1
East North Central 2 92 968 491 - 4 36 10
Illinois N NC N N N NC N N
Indiana - 28 192 156 - 0 - -
Michigan - 18 170 112 - 2 4 4
Ohio - 41 450 216 - 4 32 6
Wisconsin 2 19 156 7 - 0 - -
West North Central 6 32 329 171 - 2 12 19
Iowa N NC N N N NC N N
Kansas - 0 - - - 0 - -
Minnesota - 0 - - - 0 - -
Missouri 6 20 218 111 - 2 12 11
Nebraska - 7 52 26 - 0 - -
North Dakota - 4 23 13 - 0 - -
South Dakota - 7 36 21 - 1 - 8
South Atlantic 3 73 571 600 - 5 9 5
Delaware 3 5 41 21 - 0 - -
District of Columbia - 2 14 8 - 0 - -
Florida - 26 257 207 - 3 8 3
Georgia - 18 34 185 - 0 - -
Maryland - 11 15 84 - 0 - 1
North Carolina N NC N N N NC N N
South Carolina - 25 181 9 - 3 1 1
Virginia - 2 5 6 - 0 - -
West Virginia - 11 24 80 - 0 - -
East South Central 9 45 470 392 - 2 2 2
Alabama 3 19 137 109 - 1 1 -
Kentucky 1 12 84 44 - 2 1 2
Mississippi 4 6 72 61 - 0 - -
Tennessee 1 28 177 178 - 0 - -
West South Central 15 128 602 444 - 5 13 14
Arkansas 4 10 87 52 - 1 1 -
Louisiana - 29 69 131 - 2 2 -
Oklahoma N NC N N N NC N N
Texas 11 118 446 261 - 5 10 14
Mountain 41 94 1,199 644 1 3 14 5
Arizona 24 48 562 273 1 1 3 3
Colorado 15 28 259 129 - 1 2 -
Idaho N NC N N N NC N N
Montana - 5 34 24 - 1 - -
Nevada - 10 109 77 - 1 1 1
New Mexico - 16 144 65 - 0 - -
Utah 2 12 91 56 - 2 8 1
Wyoming - 3 - 20 - 0 - -
Pacific 4 12 87 60 - 2 6 -
Alaska 4 11 76 49 - 2 6 -
California N NC N N N NC N N
Hawaii - 3 11 11 - 0 - -
Oregon N NC N N N NC N N
Washington N NC N N N NC N N
U.S. Territories - 0 - 1 - 0 - -
American Samoa N NC N N N NC N N
Commonwealth of Northern Mariana Islands - 0 - - - 0 - -
Guam - 0 - - - 0 - -
Puerto Rico - 0 - 1 - 0 - -
U.S. Virgin Islands - 0 - - - 0 - -
Non-U.S. Residents - 0 - - - 0 - -
Total 101 453 5,120 3,379 3 14 127 73
  • U: Unavailable — The reporting jurisdiction was unable to send the data to CDC or CDC was unable to process the data.
  • -: No reported cases — The reporting jurisdiction did not submit any cases to CDC.
  • N: Not reportable — The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
  • NN: Not nationally notifiable — This condition was not designated as being nationally notifiable.
  • NP: Nationally notifiable but not published.
  • NC: Not calculated — There is insufficient data available to support the calculation of this statistic.
  • Cum: Cumulative year-to-date counts.
  • Max: Maximum — Maximum case count during the previous 52 weeks.
  • * Case counts for reporting years 2021 and 2022 are provisional and subject to change. Cases are assigned to the reporting jurisdiction submitting the case to NNDSS, if the case's country of usual residence is the U.S., a U.S. territory, unknown, or null (i.e. country not reported); otherwise, the case is assigned to the 'Non-U.S. Residents' category. Country of usual residence is currently not reported by all jurisdictions or for all conditions. For further information on interpretation of these data, see https://www.cdc.gov/nndss/docs/Readers-Guide-WONDER-Tables-20210421-508.pdf.
  • †Previous 52 week maximum and cumulative YTD are determined from periods of time when the condition was reportable in the jurisdiction (i.e., may be less than 52 weeks of data or incomplete YTD data).
  • § Includes drug resistant and susceptible cases of Invasive Pneumococcal Disease.